186 related articles for article (PubMed ID: 19445983)
1. Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
Gabriel D; Busso N; So A; van den Bergh H; Gurny R; Lange N
J Control Release; 2009 Sep; 138(3):225-34. PubMed ID: 19445983
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis.
Gabriel D; Lange N; Chobaz-Peclat V; Zuluaga MF; Gurny R; van den Bergh H; Busso N
J Control Release; 2012 Oct; 163(2):178-86. PubMed ID: 22959919
[TBL] [Abstract][Full Text] [Related]
3. Polymeric photosensitizer prodrugs for photodynamic therapy.
Campo MA; Gabriel D; Kucera P; Gurny R; Lange N
Photochem Photobiol; 2007; 83(4):958-65. PubMed ID: 17645670
[TBL] [Abstract][Full Text] [Related]
4. Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs.
Zuluaga MF; Gabriel D; Lange N
Mol Pharm; 2012 Jun; 9(6):1570-9. PubMed ID: 22548315
[TBL] [Abstract][Full Text] [Related]
5. Selective synovectomy using thrombin-sensitive photodynamic agents.
Park K
J Control Release; 2009 Sep; 138(3):224. PubMed ID: 19616048
[No Abstract] [Full Text] [Related]
6. Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis.
Trauner KB; Gandour-Edwards R; Bamberg M; Shortkroff S; Sledge C; Hasan T
Photochem Photobiol; 1998 Jan; 67(1):133-9. PubMed ID: 9477771
[TBL] [Abstract][Full Text] [Related]
7. Transdermal photodynamic therapy--a treatment option for rheumatic destruction of small joints?
Funke B; Jungel A; Schastak S; Wiedemeyer K; Emmrich F; Sack U
Lasers Surg Med; 2006 Oct; 38(9):866-74. PubMed ID: 16977613
[TBL] [Abstract][Full Text] [Related]
8. Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients.
Dietze A; Engesaeter B; Berg K
Photochem Photobiol Sci; 2005 Apr; 4(4):341-7. PubMed ID: 15803204
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic study of ALA-induced endogenous porphyrins in arthritic knee tissues: targeting rheumatoid arthritis PDT.
Bagdonas S; Kirdaite G; Streckyte G; Graziene V; Leonaviciene L; Bradunaite R; Venalis A; Rotomskis R
Photochem Photobiol Sci; 2005 Jul; 4(7):497-502. PubMed ID: 15986056
[TBL] [Abstract][Full Text] [Related]
10. On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds.
Gabriel D; Zuluaga MF; Lange N
Photochem Photobiol Sci; 2011 May; 10(5):689-703. PubMed ID: 21298150
[TBL] [Abstract][Full Text] [Related]
11. Strategies for enhanced photodynamic therapy effects.
Verma S; Watt GM; Mai Z; Hasan T
Photochem Photobiol; 2007; 83(5):996-1005. PubMed ID: 17880492
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic treatment as a novel approach in the therapy of arthritic joints.
Hansch A; Frey O; Gajda M; Susanna G; Boettcher J; Bräuer R; Kaiser WA
Lasers Surg Med; 2008 Apr; 40(4):265-72. PubMed ID: 18412224
[TBL] [Abstract][Full Text] [Related]
13. Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes.
Gabriel D; Campo MA; Gurny R; Lange N
Bioconjug Chem; 2007; 18(4):1070-7. PubMed ID: 17477499
[TBL] [Abstract][Full Text] [Related]
14. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
[TBL] [Abstract][Full Text] [Related]
15. Effect of light emitting diodes in the photodynamic therapy of rheumatoid arthritis.
Neupane J; Ghimire S; Shakya S; Chaudhary L; Shrivastava VP
Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):44-9. PubMed ID: 20230993
[TBL] [Abstract][Full Text] [Related]
16. Correlation of photosensitizer delivery to lipoproteins and efficacy in tumor and arthritis mouse models; comparison of lipid-based and Pluronic P123 formulations.
Chowdhary RK; Sharif I; Chansarkar N; Dolphin D; Ratkay L; Delaney S; Meadows H
J Pharm Pharm Sci; 2003; 6(2):198-204. PubMed ID: 12935430
[TBL] [Abstract][Full Text] [Related]
17. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection.
O'Riordan K; Akilov OE; Chang SK; Foley JW; Hasan T
Photochem Photobiol Sci; 2007 Oct; 6(10):1117-23. PubMed ID: 17914486
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis.
Fiehn C; Kratz F; Sass G; Müller-Ladner U; Neumann E
Ann Rheum Dis; 2008 Aug; 67(8):1188-91. PubMed ID: 18408252
[TBL] [Abstract][Full Text] [Related]
19. Double-PEGylated Cyclopeptidic Photosensitizer Prodrug Improves Drug Uptake from In Vitro to Hen's Egg Chorioallantoic Membrane Model.
Bouilloux J; Kiening M; Yapi S; Lange N
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684822
[TBL] [Abstract][Full Text] [Related]
20. Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer.
Suci PA; Varpness Z; Gillitzer E; Douglas T; Young M
Langmuir; 2007 Nov; 23(24):12280-6. PubMed ID: 17949022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
